Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HIV health care providers are ready to introduce pre-exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.
Kowalska JD, Bursa D, Gökengin D, Jilich D, Tomazic J, Vasylyev M, Bukovinowa P, Mulabdic V, Antonyak S, Horban A; ECEE Network Group. Kowalska JD, et al. HIV Med. 2018 Oct;19(9):629-633. doi: 10.1111/hiv.12641. Epub 2018 Jul 10. HIV Med. 2018. PMID: 29989332 Free article.
National strategies for vaccination against COVID-19 in people living with HIV in Central and Eastern European region.
Jilich D, Skrzat-Klapaczyńska A, Fleischhans L, Bursa D, Antoniak S, Balayan T, Begovac J, Cicic A, Dragovic G, Goekengin D, Harxhi A, Kase K, Lakatos B, Matulionyte R, Mulabdic V, Oprea C, Papadopoulos A, Rukhadze N, Tomazic J, Tovba L, Soják Ľ, Vassilenko A, Yancheva N, Yurin O, Kowalska J; ECEE Network Group. Jilich D, et al. Among authors: rukhadze n. HIV Med. 2022 May;23(5):546-552. doi: 10.1111/hiv.13194. Epub 2021 Oct 26. HIV Med. 2022. PMID: 34704331 Free PMC article.
Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19).
Lakatos B, Kowalska J, Antoniak S, Gokengin D, Begovac J, Vassilenko A, Wasilewski P, Fleischhans L, Jilich D, Matulionyte R, Kase K, Papadopoulus A, Rukhadze N, Harxhi A, Hofman S, Dragovic G, Vasyliev M, Verhaz A, Yancheva N, Oprea C; Euroguideliness in Central and Eastern Europe (ECEE) Network Group. Lakatos B, et al. Among authors: rukhadze n. HIV Med. 2022 Jul;23(6):693-700. doi: 10.1111/hiv.13214. Epub 2021 Dec 3. HIV Med. 2022. PMID: 34859557 Free article.
36 results